Clinical trials of RA 27-3 (Wistar) rubella vaccine in Japan.
D000029:Abortion, Legal; D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D046508:Culture Techniques; D005260:Female; D005333:Fetus / Q000382:microbiology; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D007564:Japan; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D014556:Urine / Q000382:microbiology; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines